Ben is Chief Medical Officer at Alchemab Therapeutics, where he leads clinical development and medical strategy. He has more than 20 years of drug development with particular focus in immune-mediated and inflammatory diseases.

Prior to joining Alchemab, Ben was Chief Medical Officer at ImageneBio and, previously, at MoonLake Immunotherapeutics. Before MoonLake, he was VP of Clinical Development at Kymab and Sanofi.

Earlier in his career, Ben spent 16 years at Roche Pharmaceuticals, including as Global Development Leader in immunology and Global Head of Infectious Diseases for Late-Stage Development.

Ben trained in medicine at Imperial College London and holds a Pharmacology with Medical Sciences degree from the University of London.